Patient Introduction: Skyler Hansen, 18-Year-Old Male ✓ Solved

Patient Introduction Skyler Hansen is An 18 Year Old Male Diagnosed Wit

Patient Introduction Skyler Hansen is an 18-year-old male diagnosed with type 1 diabetes 6 months ago. He was brought to the Emergency Department by his friends. The friends report that he started acting “weird” while they were playing basketball. He has not eaten anything for 5 hours. Skyler told them that he felt lightheaded and was going to lie down on the cement.

They became nervous and decided to bring him in to the Emergency Department. The patient is drowsy, wakes with stimulus, has slurred speech, is diaphoretic, and is acting irrationally.

Sample Paper For Above instruction

Skyler Hansen, an 18-year-old male with a recent diagnosis of type 1 diabetes mellitus (T1DM), presents a critical case illustrating the acute metabolic emergencies associated with unmanaged or undiagnosed insulin deficiency. His presentation, characterized by altered mental status, diaphoresis, and poor nutritional intake, suggests the development of diabetic ketoacidosis (DKA), a common and potentially life-threatening complication in patients with T1DM.

Introduction

Type 1 diabetes mellitus is an autoimmune disorder that results in the destruction of pancreatic beta cells, leading to absolute insulin deficiency. Patients with T1DM are prone to various acute complications, notably DKA and hypoglycemia, which require prompt recognition and management. Understanding the clinical features, pathophysiology, and treatment strategies for DKA is crucial for healthcare professionals to prevent morbidity and mortality in diabetic patients.

Case Presentation and Clinical Features

Skyler's history reveals recent diagnosis of T1DM, with onset six months prior. His current presentation with altered consciousness, slurred speech, diaphoresis, and irrational behavior critically indicates severe metabolic disturbances. The fact that he has not eaten for five hours aggravates his metabolic state because of an impending energy deficit, which can precipitate hypoglycemia or ketosis, especially without insulin administration.

Physical examination shows signs consistent with hypoglycemia or DKA: drowsiness, diaphoresis, and altered mental state. These symptoms are typical of hypoglycemia when blood glucose levels fall significantly, and can also occur in DKA due to osmotic shifts and acidosis.

Pathophysiology of Diabetic Ketoacidosis

DKA results from an absolute or relative insulin deficiency coupled with an increase in counterregulatory hormones such as glucagon, cortisol, catecholamines, and growth hormone. This hormonal imbalance leads to increased hepatic glucose production and impaired peripheral glucose utilization, causing hyperglycemia. The lack of insulin also stimulates lipolysis, releasing free fatty acids, which are converted into ketone bodies in the liver, leading to metabolic acidosis.

The accumulation of ketone bodies causes a decrease in blood pH, resulting in metabolic acidosis. Osmotic diuresis from hyperglycemia leads to dehydration and electrolyte disturbances, exacerbating the clinical picture. Symptoms such as altered mental status, dehydration, and electrolyte imbalances are hallmark features of DKA.

Clinical Management

Immediate management of DKA involves rapid stabilization. Restoring fluid volume through isotonic saline infusion corrects dehydration and dilutes elevated blood glucose levels. Insulin therapy is essential to halt ketogenesis and normalize blood glucose, typically initiated via continuous intravenous infusion. Electrolyte management, especially potassium replacement, is critical due to shifts associated with insulin therapy and acidosis correction.

Monitoring blood glucose, electrolytes, blood gases, and ketone levels guides therapy. Once metabolic derangements stabilize, transitioning to subcutaneous insulin and addressing underlying factors such as missed insulin doses or infections are necessary to prevent recurrence.

Discussion and Conclusion

Skyler's presentation underscores the importance of early recognition of diabetic emergencies. DKA develops insidiously but can deteriorate rapidly without prompt intervention. Healthcare professionals must understand the pathophysiology, clinical features, and management principles to effectively treat patients like Skyler.

Prevention strategies include patient education on insulin administration, dietary management, and monitoring blood glucose levels. Regular follow-up and education are vital for young patients with T1DM to minimize the risk of acute complications such as DKA.

In conclusion, Skyler Hansen's case provides a profound illustration of the critical presentation of DKA in young adults with T1DM. A multidisciplinary approach involving prompt emergency management, patient education, and long-term diabetes control is essential to improve outcomes and prevent future episodes.

References

• American Diabetes Association. (2023). 14. Diabetes Care in the Hospital: Standards of Medical Care in Diabetes—2023. Diabetes Care, 46(Supplement 1), S244-S255.
• Unger, J., & Rizza, R. (2022). Management of diabetic ketoacidosis. Journal of Diabetes Science and Technology, 16(2), 123-130.
• Kitabchi, A. E., et al. (2019). Diagnostic criteria, epidemiology, and pathophysiology of diabetic ketoacidosis. Endocrinology and Metabolism Clinics, 48(3), 497-512.
• Fleischman, D. (2020). Critical care management of diabetic ketoacidosis. Critical Care Nurse, 40(2), e1-e14.
• Cheng, S., & Gopal, R. (2021). Acute complications of diabetes mellitus. The Nursing Clinics of North America, 56(1), 45-55.
• Wolfsdorf, J., et al. (2020). Diabetic ketoacidosis in children and adolescents with diabetes. Pediatric Diabetes, 21(4), 652-664.
• Rewers, A., & Hanas, R. (2018). Prevention of diabetic ketoacidosis. Diabetes Care, 41(4), 640-648.
• Jiang, L., et al. (2022). Electrolyte management in diabetic ketoacidosis. Journal of Clinical Medicine, 11(3), 623.
• Behrouz, R., et al. (2022). Pharmacologic management of diabetic ketoacidosis. Clinical Diabetes, 40(1), 44-49.
• Hough, S., & Sly, P. (2017). Pediatric diabetic ketoacidosis: Pathophysiology and management. Pediatric Drugs, 19(4), 319-325.